Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Finland

Marie Skłodowska-Curie Action · Running

BRIDGE-AI BRaIn Disease monitoring throuGh the lifE span powered by Artificial Intelligence

Coordinator
Aalto Korkeakoulusaatio Sr, Finland
Runs
1 November 2025 to 31 October 2029
Status
Running
EU funding
€3.6m
Total cost
—
Partners
18 organisations in 7 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101225642

What the project is doing

In the project's own words, from its summary on CORDIS.

BRIDGE-AI will train a new generation of innovative and entrepreneurial-oriented doctoral candidates (DCs) to move the state-of-the-art away from the snapshot interpretation of medical images by AI to a longitudinal follow-up and prediction of disease progression, covering a wide range of brain disorders across the entire lifespan. In an innovative departure of prevalent training models, each of BRIDGE-AI's DCs will be co-supervised by internationally leading experts from university research in biomedical image computing, world-renowned research hospitals, leading scanner manufacturers (Siemens, Philips) and medical imaging AI companies (incl.

Bayer). Through this unique network, BRIDGE-AI will complete the entire circle from clinical needs to image acquisition, academic AI solution proposal, and commercial product for tracking disease progression and predicting treatment response in individual patients. Each of BRIDGE-AI's DCs will have a dedicated multidisciplinary and multisectoral thesis board, receiving input from industry, academia, and hospitals, and having access to large collections of clinical neuroimaging data, facilitating the evaluation of the true clinical relevance and impact of the proposed disease monitoring tools.

Wide dissemination of the obtained methodological advances will be ensured by adopting a strong network-wide focus on open-source software.

Topics

Who is involved

OrganisationCityCountryRole
Aalto Korkeakoulusaatio SrEspooFinlandCoordinator
Contextflow GmbHWienAustriaAssociatedpartner
Medizinische Universitaet WienWienAustriaParticipant
Icometrix NVLeuvenBelgiumParticipant
Universite Catholique De LouvainLouvain La NeuveBelgiumAssociatedpartner
Centre Hospitalier Universitaire VaudoisLausanneSwitzerlandAssociatedpartner
Siemens Healthineers International AGZurichSwitzerlandAssociatedpartner
Universitaet BernBernSwitzerlandAssociatedpartner
Universitatsspital BaselBaselSwitzerlandAssociatedpartner
Universite De LausanneLausanneSwitzerlandAssociatedpartner
Bayer Pharma AGBerlinGermanyAssociatedpartner
Deutsches Zentrum Fur Neurodegenerative Erkrankungen eVBonnGermanyParticipant
Rheinische Friedrich-Wilhelms-Universitat BonnBonnGermanyAssociatedpartner
Universitatsklinikum BonnBonnGermanyAssociatedpartner
Philips Medical Systems Nederland BVBestNetherlandsAssociatedpartner
Technische Universiteit EindhovenEindhovenNetherlandsParticipant
Universitair Medisch Centrum UtrechtUtrechtNetherlandsAssociatedpartner
Athinoula A. Martinos Center for Biomedical ImagingCharlestownUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI